As U.S. Reels from COVID-19, Trump Backs Gilead’s Exclusive Patent on Treatment & Suspends EPA Rules
April 2, 2020
101,397
2,293
742
2.99%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Amy Goodman Episodes Around April 2, 2020
See what was published immediately before and after this episode.
20:12Now PlayingAs U.S. Reels from COVID-19, Trump Backs Gilead’s Exclusive Patent on Treatment & Suspends EPA Rules
YouTube Description
as posted by the channelAs the United States leads the world in coronavirus cases, the nation’s healthcare system is already stretched to capacity and protective gear in short supply. President Trump and his health advisors say more than 100,000 Americans could die from the coronavirus in the next two weeks. Meanwhile, millions of people have lost their jobs, and a record 6.6 million unemployment claims were filed this week, on top of last week’s 3.3 million claims. For more on the economic impacts of the coronavirus, and how Trump has responded to the pandemic by rewarding pharmaceutical corporations like Gilead Sciences and indefinitely suspending environmental regulations, we speak with Robert Weissman, president of Public Citizen.
#DemocracyNow #Coronavirus
Democracy Now! is an independent global news hour that airs on nearly 1,400 TV and radio stations Monday through Friday. Watch our livestream 89AM ET
Please consider supporting independent media by making a donation to Democracy Now! today
FOLLOW DEMOCRACY NOW! ONLINE:
Daily Email Digest
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.